| P2093 | author name string | Pischon T | |
| | Sharma AM | |
| P2860 | cites work | Obesity as a determinant for response to antihypertensive treatment | Q28378644 |
| | Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 |
| | Obesity and cardiovascular hemodynamic function | Q34028174 |
| | Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis | Q34169434 |
| | Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity | Q34299884 |
| | Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial | Q34502430 |
| | The peripheral sympathetic nervous system in human obesity. | Q34741787 |
| | Long term propranolol treatment and changes in body weight after myocardial infarction | Q35168635 |
| | Stimulation of thermogenesis by carbohydrate overfeeding. Evidence against sympathetic nervous system mediation | Q35205662 |
| | Effects of antihypertensive therapy on insulin resistance | Q35250064 |
| | Clinical pharmacology of beta 3-adrenoceptors | Q36093779 |
| | Metabolic considerations in the choice of therapy for the patient with hypertension | Q36482909 |
| | Obesity, the sympathetic nervous system, and essential hypertension | Q36737325 |
| | Beta-adrenoceptor blockade and exercise. An update | Q39468056 |
| | Overweight is risking fate. Definition, classification, prevalence, and risks | Q39661318 |
| | Sympathetic overactivity in hypertension. A moving target | Q40922339 |
| | Thermic effect of glucose in man. Obligatory and facultative thermogenesis | Q40926661 |
| | The thermic effect of food and obesity: a critical review | Q41693261 |
| | Influence of beta-adrenergic blockade on glucose-induced thermogenesis in man | Q42789973 |
| | Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity | Q43646690 |
| | Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa | Q43719943 |
| | Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group | Q44017266 |
| | Arterial baroreceptor reflex function in borderline hypertensive rats | Q44121284 |
| | The disease burden associated with overweight and obesity | Q44817527 |
| | Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twenty four-hour energy expenditure | Q47185923 |
| | Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients | Q47298740 |
| | Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. | Q51557409 |
| | Impairment of health and quality of life in people with large waist circumference. | Q53581208 |
| | Role of nonexercise activity thermogenesis in resistance to fat gain in humans. | Q55068194 |
| | Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene | Q57242065 |
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| | arterial hypertension | Q41861 |
| | weight gain | Q3403879 |
| P304 | page(s) | 275-280 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Obesity Reviews | Q15716706 |
| P1476 | title | Use of beta-blockers in obesity hypertension: potential role of weight gain | |
| P478 | volume | 2 | |